Lipoic acid offers no improvements in walking speed or other outcomes in patients with progressive multiple sclerosis ...

People with higher blood levels of certain manufactured compounds that persist in the environment are more likely to be ...

A single dose of Immutep’s MS therapy, IMP761, was well tolerated and reduced T-cell activity for up to 23 days in healthy ...

Find out how combined chemical exposures and genetics may raise multiple sclerosis risk in new population research.

WEDNESDAY, Dec. 17, 2025 (HealthDay News) — An over-the-counter supplement called lipoic acid might help slow the loss of ...

The association between multiple sclerosis and a diet focusing on fresh produce, fish, and olive oil is particularly strong ...

The over‐the‐counter supplement lipoic acid may have a small beneficial effect in slowing the loss of gray matter in the ...

—To clarify the role that stigma plays in the mental health and quality of life in people with MS, researchers conducted an MS-specific retrospective data review. They found that stigma was associated ...

Ocrelizumab is one of three B-cell therapies approved by the FDA to treat MS. This medicine sticks to B cells and keeps them from causing damage. It has the approval to treat: Clinically isolated ...

Multiple sclerosis is an autoimmune disease that currently affects as many as one million Americans, according to the National Multiple Sclerosis Society. A new study has revealed how a compound found ...

A team of researchers at Kessler Foundation studied the effects of methylphenidate on mental fatigue in individuals with multiple sclerosis (MS). This is the first study to examine the psychostimulant ...